New hope in the fight against pain: Analgesic drugs could be used to...

Drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain, an international study reports, for the first time. An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.

http://ift.tt/1DIFh9v